159 related articles for article (PubMed ID: 11338013)
21. Tumor necrosis factor-alpha inhibits collagen synthesis in human and rat granulation tissue fibroblasts.
Rapala KT; Vähä-Kreula MO; Heino JJ; Vuorio EI; Laato MK
Experientia; 1996 Jan; 52(1):70-4. PubMed ID: 8575563
[TBL] [Abstract][Full Text] [Related]
22. Mast cells and angiogenesis in wound healing.
Gaber MA; Seliet IA; Ehsan NA; Megahed MA
Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):32-40. PubMed ID: 24902369
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes.
Laato M; Kähäri VM; Niinikoski J; Vuorio E
Biochem J; 1987 Oct; 247(2):385-8. PubMed ID: 3501286
[TBL] [Abstract][Full Text] [Related]
24. The effects of interleukin-1 and prostaglandin E2 on accumulation of collagen and steady-state levels of pro alpha 1(I) collagen messenger RNA in experimental granulation tissue in rats.
Rapala K; Heino J; Peltonen J; Laato M
Arch Dermatol Res; 1997 Mar; 289(4):219-23. PubMed ID: 9143738
[TBL] [Abstract][Full Text] [Related]
25. Mathematical modelling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring.
Cobbold CA; Sherratt JA
J Theor Biol; 2000 May; 204(2):257-88. PubMed ID: 10887905
[TBL] [Abstract][Full Text] [Related]
26. [Collagen metabolism in hypertrophic and keloid scars].
Del'vig AA
Vestn Ross Akad Med Nauk; 1995; (12):41-5. PubMed ID: 8664602
[TBL] [Abstract][Full Text] [Related]
27. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
29. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
30. [The effects of PDGF-AB on pro alpha 1 (III). mRNA expression of fibroblasts].
Dong M; Chen B; Xu M
Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):78-80. PubMed ID: 11593623
[TBL] [Abstract][Full Text] [Related]
31. Collagen type IV and procollagen type III during granulation tissue formation: a serological, biochemical, immunohistochemical and morphometrical study on the viscose cellulose sponge rat model.
Hørslev-Petersen K; Pedersen LR; Bentsen KD; Brocks D; Garbarsch C; Kim KY; Hahn EG; Schuppan D; Lorenzen I
Eur J Clin Invest; 1988 Aug; 18(4):352-9. PubMed ID: 3139420
[TBL] [Abstract][Full Text] [Related]
32. Variations in gap junctional intercellular communication and connexin expression in fibroblasts derived from keloid and hypertrophic scars.
Lu F; Gao J; Ogawa R; Hyakusoku H
Plast Reconstr Surg; 2007 Mar; 119(3):844-51. PubMed ID: 17312486
[TBL] [Abstract][Full Text] [Related]
33. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar.
Zhang K; Garner W; Cohen L; Rodriguez J; Phan S
J Invest Dermatol; 1995 May; 104(5):750-4. PubMed ID: 7738352
[TBL] [Abstract][Full Text] [Related]
34. Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective.
van den Broek LJ; Limandjaja GC; Niessen FB; Gibbs S
Exp Dermatol; 2014 Jun; 23(6):382-6. PubMed ID: 24750541
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology, aetiology and management of abnormal scarring: a review of the literature.
Pellard S
J Wound Care; 2006 Jan; 15(1):44-8. PubMed ID: 16669306
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars.
Wong VW; You F; Januszyk M; Gurtner GC; Kuang AA
Ann Plast Surg; 2014; 72(6):711-9. PubMed ID: 24835866
[TBL] [Abstract][Full Text] [Related]
37. Human granulation-tissue fibroblasts show enhanced proteoglycan gene expression and altered response to TGF-beta 1.
Häkkinen L; Westermarck J; Kähäri VM; Larjava H
J Dent Res; 1996 Oct; 75(10):1767-78. PubMed ID: 8955672
[TBL] [Abstract][Full Text] [Related]
38. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
39. Double-edged effects of neuropeptide substance P on repair of cutaneous trauma.
Jing C; Jia-Han W; Hong-Xing Z
Wound Repair Regen; 2010; 18(3):319-24. PubMed ID: 20412553
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of pathological scarring: role of myofibroblasts and current developments.
Sarrazy V; Billet F; Micallef L; Coulomb B; Desmoulière A
Wound Repair Regen; 2011 Sep; 19 Suppl 1():s10-5. PubMed ID: 21793960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
